Skip to main content
SPARC - Logo
Innovations Inspired by life
Menu

Hamburger

  • Our Company
    • Who we are
    • History
    • Culture
    • Board of Directors
    • Leadership Team
  • OUR RESEARCH
    • Therapeutic focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline
  • Our Medicines
    • Xelpros®
    • Elepsia® XR
  • Business Development
    • Strategy
    • Partner with us
  • Accreditations And Approvals
    • Good Laboratory Practice
  • Investors
    • Who we are
    • Financials
    • Annual reports
    • Presentations
    • Chairman's Speech
    • Committees of BOD's
    • Shareholding pattern
    • Announcements & Disclosures
    • Policies & Codes
    • Listing Information
    • Board of Directors
    • FAQ’s, Guide Book and Forms for Shareholders
    • Investors Contact
    • Go green
    • IEPF
  • Media
    • Press Releases
    • Presentations
  • Careers
    • Overview
    • Apply Now
  • Contact Us
Home » Investor Education Protection Fund (IEPF) - Nodal Officer Details

Investors Menu

  • Investors
    • Who we are
    • Financials
    • Annual Reports
    • Presentations
    • Chairman's Speech
    • Committees of BOD's
    • Shareholding Pattern
    • Announcements & Disclosures
    • Policies & Codes
    • Listing Information
    • Board of Directors
    • FAQ’s, Guide Book and Forms for Shareholders
    • Investors Contact
    • Go Green
    • IEPF

Investor Education Protection Fund

Dear Shareholders,

As you may be aware, in terms of section 125 of the Companies Act, 2013, the Company is, inter alia, required to transfer any excess application money received by it for allotment of any securities and due for refund which is lying unclaimed / unpaid with the Company for more than 7 (seven) years to the Investor Education & Protection Fund set up by the Government under section 124 of the Companies Act, 2013 (‘IEPF’).

The Company holds certain unclaimed/ unpaid fund against Share Application Money received by it during its Rights Issues, which will/ has become due for transfer to the aforesaid Fund on the expiry of 7 (seven) years from the due date for refund of the excess application money received by the Company for the respective Issue.

Pursuant to rule 5 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, the particulars of unclaimed amounts as on the date of closure of the previous Financial Year is provided herein below for the information of the concerned shareholders.

In order to verify whether any unclaimed amount is due for refund to you by the Company, you are requested to enter the Name of the first holder or the Folio No./ DP ID & Client ID in the table below to retrieve the same:

 

In case any unclaimed amount is lying with the Company as on date, you are requested to write to the Company or our Registrar & Share Transfer Agents – Link Intime (India) Pvt. Ltd. well before the due date for transfer of such amount to IEPF. In case your amount has already been transferred to the IEPF, you may directly approach the Investor Education & Protection Fund Authority for the same.For any other assistance regarding the unclaimed amount, you may contact Mr. Debashis Dey, Company Secretary, who has also been appointed by the Board as the Nodal Officer for the Investor Education and Protection Fund. His contact details are as follows:

Investor Education Protection Fund (IEPF)
(Nodal Officer Details)

Dinesh Lahoti

17 B Mahal Industrial Estate,
Mahakali Caves Rd Andheri (E),
Mumbai - 400 093.

Tel: +91 22 6645 5645
Fax: +91 22 6645 5685

Email: dinesh.lahoti@sparcmail.com

Our Company

  • Who we are
  • history
  • Culture
  • board of directors
  • Leadership team

Our Research

  • Therapeutic focus
  • Delivery Technologies
  • Research Programs
  • R&D Pipeline

Investor Relations

  • Financials
  • Announcements & Disclosures
  • Shareholding pattern
  • Listing Information

Quick Links

Quick Links

  • Business Development
  • Investors
  • Media
  • Careers

Social Connect

  • twitter
  • linkedin

Employee Portal »

Copyright © 2019. Sun Pharma Advanced Research Company Ltd. All rights reserved.
Terms of Use  |   Archival Policy   |   Sitemap
Site Credits